General Biologicals Corp. (GBC), founded in 1984, is the industry-leading in-vitro diagnostic device manufacturer in Taiwan. GBC is certified with IVD Class III, GMP and ISO 13485:2003. GBC has offices in Taipei.
Showing 1–12 of 58 results
For in-vitro qualitative detection of Hepatitis D virus infection in human serum or plasma
For in vitro quantitative detection of Antibody to Hepatitis B surface antigen (Anti-HBs) in human serum or plasma.
The test can be used prior and after hepatitis B vaccination to assess the immune status as well as an aid to diagnose and monitor infections by hepatitis B virus.
For in-vitro qualitative detection and screening assay of HIV infection in human serum or plasma.
GB KIWI™ eGILITY has a proven track record of quality, innovation and reliability as a worldwide leader in fully automated systems and consumables.
GB KIWI™ e4000 offers flexible and reliable sample-in/result-out processing, designed for true walk-away automation.
Automation, accuracy, immediacy and responsiveness are the must-haves of demanding near-patient-care settings and lower-throughput labs.
The measurement of Ferritin in serum is useful in determining changes in body iron storage, and is non-invasive with relatively little patient discomfort. Serum Ferritin levels can be measured routinely and are particularly useful in the early detection of iron- deficiency anemia in apparently healthy people. Serum Ferritin measurements are also clinically significant in the monitoring of the iron status of pregnant women, blood donors, and renal dialysis patients.
The HGH Human ELISA Kit is designed to quantify protein levels of human HGH in serum and plasma. Human growth hormone (HGH) acts to indirectly induce growth on target tissues.
For the quantitative determination of Immunoglobulin E (IgE) concentration in human serum.
Helicobacter pylori IgG Test Kit is intended for use in evaluating the serologic status to H. pylori infection in patients with gastrointestinal symptoms.
H. Pylori IgM
The Rubella IgG ELISA is intended for use in evaluating a patient’s serologic status to the rubella virus infection. It is also used to evaluate paired sera for the presence of a significant increase in specific Rubella IgG as indication of a recent or current rubella virus infection.